Abstract:Background: Acute lung injury (ALI) and its more severe form, acute respiratory distress syndrome (ARDS) are life threatening pulmonary diseases, and we are now lack of effective therapeutic methods. Inflammatory responses are essential for initiating ALI/ARDS. Thus, ameliorating inflammatory reaction might be beneficial for treatment of the disease. There are increasing data that phosphodiesterase-4 (PDE4)-selective inhibitors, which may elevate cellular cyclic adenosine 3', 5'-monophosphate (cAMP) level, could suppress inflammation. However, whether they could be used to treat IgG immune complex (IgG-IC)-associated ALI has not been determined.Methods: ALI is induced by treating mice with airway deposition of IgG immune complexes. Cellular cAMP concentrations are elevated by treating mice or macrophages with Rolipram/Roflumilast. The degree of pulmonary injury is reflected by lung permeability, leukocyte accumulation, histological change and expressions of pro-inflammatory mediators. 6-Bnz-cAMP and H-89 are used to regulate protein kinase A (PKA) activity, and 8-pCPT-2'-O-Me-cAMP is applied to activate exchange proteins directly activated by cAMP (Epac). Gene expressions are analyzed by real-time PCR, ELISA or Western blot. CCAAT/enhancer binding protein (C/EBP) and activation protein 1 (AP-1) transcription activities are estimated by measuring the luciferase productions.Results: IgG-IC-induced ALI is attenuated by the PDE4-selective inhibitor, which is due to reduced expressions of cytokine and chemokines. Interestingly, we find that cAMP downstream effector molecule PKA but not Epac is involved in negative regulation of IgG-IC-mediated pro-inflammatory mediators' productions. Mechanistically, activation of cAMP-PKA signal axis leads to inactivation of MAPK pathway, resulting in a decrease in C/EBP- and AP-1-mediated transcriptions of pro-inflammatory mediators.Conclusions: Our data demonstrate, for the first time, that cAMP-PKA signal is involved in down-regulation of IgG-IC-associated inflammatory responses via down-regulating MAPK activation, which is critical for transcriptional activities of C/EBP and AP-1. Collectively, our experiments provide theoretical base for the potential application of PDE4-selective inhibitor to clinic for treatment of IgG-IC-related acute lung injury.

Downregulation of CIITA Function by Protein Kinase A (Pka)-Mediated Phosphorylation: Mechanism of Prostaglandin E, Cyclic AMP, and PKA Inhibition of Class II Major Histocompatibility Complex Expression in Monocytic Lines

Cloning of Human Preprotachykinin-I Promoter and the Role of Cyclic Adenosine 5 '-Monophosphate Response Elements in Its Expression by Il-1 and Stem Cell Factor

IgG Immune Complex-Induced Acute Lung Injury is Ameliorated by Camp Via Down-Regulation of C/EBP- and AP-1-mediated Transcriptions.

Phosphatase SHP-1 Promotes TLR- and RIG-I-activated Production of Type I Interferon by Inhibiting the Kinase IRAK1

Down-Regulation Of Mhc Class Ii Expression Through Inhibition Of Ciita Transcription By Lytic Transactivator Zta During Epstein-Barr Virus Reactivation

The Dual Functions of IL-1 Receptor-Associated Kinase 2 in TLR9-Mediated IFN and Proinflammatory Cytokine Production

Mhc Class Ii Transactivator Represses Human Il-4 Gene Transcription by Interruption of Promoter Binding with Cbp/P300, Stat6 and Nfat1 Via Histone Hypoacetylation

Methylation of CIITA promoter IV causes loss of HLA-II inducibility by IFN-gamma in promyelocytic cells

Mutated major histocompatibility complex class II transactivator up-regulates interleukin-33-dependent differentiation of Th2 subset through Nod2 binding for NLR (NOD-like receptor) signaling initiation

Inhibition of antibodies to CD3 surface antigen and phytohemagglutinin-mediated T cellular responses by inhibiting Ca2+/phospholipid-dependent protein kinase activity with the aid of 1-(5-isoquinolinylsulfonyl)-2-methylpiperazine dihydrochloride.

Regulation of cytokine-independent survival kinase (CISK) by the Phox homology domain and phosphoinositides

CIITA-regulated plexin-A1 affects T-cell–dendritic cell interactions

Interferon type I downregulates human parainfluenza virus type 3-induced major histocompatibility complex class II expression

A protein kinase involved in the regulation of inflammatory cytokine biosynthesis

A2b adenosine signaling represses CIITA transcription via an epigenetic mechanism in vascular smooth muscle cells.

CIP2A Constrains Th17 Differentiation by Modulating STAT3 Signaling

The role of class I histocompatibility antigens in the regulation of T-cell activation

PKA-RII subunit phosphorylation precedes activation by cAMP and regulates activity termination

Cpkcβii-Interacting ERK1/2 Protein Levels Decreased in the Hippocampus of Hypoxic Preconditioned Mice

Protein Kinase C Activation Inhibits Tyrosine Phosphorylation Of Cbl And Its Recruitment Of Src Homology 2 Domain-Containing Proteins

Guanine nucleotide regulation of inositol phospholipid hydrolysis and CD3-antigen phosphorylation in permeabilized T lymphocytes